NovoCure (NVCR) Accumulated Expenses (2014 - 2018)

NovoCure's Accumulated Expenses history runs 5 years deep, the most recent figure standing at $16.7 million for Q4 2018.

• In Q4 2018, Accumulated Expenses rose 25.85% year-over-year to $16.7 million; the TTM figure through Dec 2018 stood at $16.7 million (up 25.85% YoY), while the FY2018 annual figure was $16.7 million, up 25.85% from the prior year.
• Accumulated Expenses came in at $16.7 million for Q4 2018 at NovoCure, up from $13.3 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $16.7 million in Q4 2018 to a low of $5.8 million in Q4 2014.
• A 5-year average of $10.3 million and a median of $8.3 million in 2015 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses declined 8.68% in 2016 and jumped 76.14% in 2017, its largest moves.
• NovoCure's Accumulated Expenses stood at $5.8 million in 2014, then jumped by 41.26% to $8.3 million in 2015, then slipped by 8.68% to $7.5 million in 2016, then surged by 76.14% to $13.3 million in 2017, then grew by 25.85% to $16.7 million in 2018.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $16.7 million, $13.3 million, and $7.5 million for Q4 2018, Q4 2017, and Q4 2016 respectively.

Peer Comparison